Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)

D. Elias; H. Vever; A. V. Lænkholm; M. F. Gjerstorff; C. W. Yde; A. E. Lykkesfeldt; H. J. Ditzel

doi:10.1038/s41388-018-0495-6

Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)

D. Elias^*, H. Vever, A. V. Lænkholm, M. F. Gjerstorff, C. W. Yde, A. E. Lykkesfeldt, H. J. Ditzel

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

115 Downloads (Pure)

Abstrakt

Since the online publication of the above article, the authors have noted errors in subfigures 1c and 3b. Therefore, new images of the original immmunocytochemistry stainings have been obtained for Fig. 1c, and the Western blots for siRNA-mediated FYN knockdown in Fig. 3b were repeated. The amended versions of Figs. 1c and 3b are now provided.

Originalsprog	Engelsk
Tidsskrift	Oncogene
Vol/bind	37
Udgave nummer	41
Sider (fra-til)	5585–5586
ISSN	0950-9232
DOI	https://doi.org/10.1038/s41388-018-0495-6
Status	Udgivet - okt. 2018

Dokumenter og links

10.1038/s41388-018-0495-6Licens: CC BY

Correction to Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapyForlagets udgivne version, 852 KBLicens: CC BY

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)'. Sammen danner de et unikt fingeraftryk.

1 Kommentar/debat

Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)
Elias, D., Vever, H., Lænkholm, A. V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E. & Ditzel, H. J., mar. 2020, I: Oncogene. 39, 10, s. 2229-2230
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Åben adgang
Fil
27 Downloads (Pure)

Citationsformater

Elias, D., Vever, H., Lænkholm, A. V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., & Ditzel, H. J. (2018). Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138). Oncogene, 37(41), 5585–5586 . https://doi.org/10.1038/s41388-018-0495-6

@article{d3f4f19579454447862fabc94e0e931c,

title = "Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)",

abstract = "Since the online publication of the above article, the authors have noted errors in subfigures 1c and 3b. Therefore, new images of the original immmunocytochemistry stainings have been obtained for Fig. 1c, and the Western blots for siRNA-mediated FYN knockdown in Fig. 3b were repeated. The amended versions of Figs. 1c and 3b are now provided.",

author = "D. Elias and H. Vever and L{\ae}nkholm, {A. V.} and Gjerstorff, {M. F.} and Yde, {C. W.} and Lykkesfeldt, {A. E.} and Ditzel, {H. J.}",

year = "2018",

month = oct,

doi = "10.1038/s41388-018-0495-6",

language = "English",

volume = "37",

pages = "5585–5586 ",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "41",

}

Elias, D, Vever, H, Lænkholm, AV, Gjerstorff, MF, Yde, CW, Lykkesfeldt, AE & Ditzel, HJ 2018, 'Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)', Oncogene, bind 37, nr. 41, s. 5585–5586 . https://doi.org/10.1038/s41388-018-0495-6

Correction to : Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138). / Elias, D.; Vever, H.; Lænkholm, A. V. et al.

I: Oncogene, Bind 37, Nr. 41, 10.2018, s. 5585–5586 .

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

TY - JOUR

T1 - Correction to

T2 - Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)

AU - Elias, D.

AU - Vever, H.

AU - Lænkholm, A. V.

AU - Gjerstorff, M. F.

AU - Yde, C. W.

AU - Lykkesfeldt, A. E.

AU - Ditzel, H. J.

PY - 2018/10

Y1 - 2018/10

N2 - Since the online publication of the above article, the authors have noted errors in subfigures 1c and 3b. Therefore, new images of the original immmunocytochemistry stainings have been obtained for Fig. 1c, and the Western blots for siRNA-mediated FYN knockdown in Fig. 3b were repeated. The amended versions of Figs. 1c and 3b are now provided.

AB - Since the online publication of the above article, the authors have noted errors in subfigures 1c and 3b. Therefore, new images of the original immmunocytochemistry stainings have been obtained for Fig. 1c, and the Western blots for siRNA-mediated FYN knockdown in Fig. 3b were repeated. The amended versions of Figs. 1c and 3b are now provided.

U2 - 10.1038/s41388-018-0495-6

DO - 10.1038/s41388-018-0495-6

M3 - Comment/debate

C2 - 30242243

AN - SCOPUS:85053678231

VL - 37

SP - 5585

EP - 5586

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 41

ER -

Elias D, Vever H, Lænkholm AV, Gjerstorff MF, Yde CW, Lykkesfeldt AE et al. Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138). Oncogene. 2018 okt.;37(41):5585–5586 . doi: 10.1038/s41388-018-0495-6

Correction to: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)

Abstrakt

Dokumenter og links

Fingeraftryk

Relaterede publikationer

Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)

Citationsformater